Vanguard Capital Management
RPID icon

Vanguard Capital Management’s Rapid Micro Biosystems RPID Stock Holding History

Vanguard Capital Management’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.7M Sell
982,034
-460
-0% -$969 ﹤0.01% 3470
2026
Q1 		$2.23M Buy
+982,494
New +$3.6M ﹤0.01% 3326

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $8.55M AUM 12.76% 1-Year Est. Return
EFA
Evernest Financial Advisors Carmel, Indiana $478M AUM 24% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management's RPID Position: Q2 2026 in Review

Vanguard Capital Management reduced its Rapid Micro Biosystems (RPID) stake by 0.05% in Q2 2026, selling an estimated $969 and leaving 982,034 shares worth $1.7M. The position accounts for ﹤0.01% of the portfolio, ranked #3470.

Vanguard Capital Management first reported a position in RPID in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.23M in Q1 2026. 32 funds tracked by Wall St. Rank hold RPID as of Q2 2026.

  • Vanguard Capital Management held 982,034 shares of Rapid Micro Biosystems worth $1.7M as of Q2 2026.
  • Vanguard Capital Management sold 460 Rapid Micro Biosystems shares in Q2 2026, an estimated $969.
  • Rapid Micro Biosystems made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3470 holding.
  • Vanguard Capital Management first reported a position in Rapid Micro Biosystems in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Rapid Micro Biosystems position peaked at $2.23M in Q1 2026.
  • 32 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.